Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources

[1]  A. Bayraktar-Ekincioglu,et al.  Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients , 2020, Journal of managed care & specialty pharmacy.

[2]  G. Cınar,et al.  Pattern of systemic antibiotic use and potential drug interactions: evaluations through a point prevalence study in Ankara University Hospitals , 2020, Turkish journal of medical sciences.

[3]  R. Manfro,et al.  Immunosuppression in Kidney Transplantation: State of the Art and Current Protocols. , 2020, Current pharmaceutical design.

[4]  T. Salgado,et al.  Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review , 2019, International Journal of Clinical Pharmacy.

[5]  G. Riu-Viladoms,et al.  Drug interactions with oral antineoplastic drugs: The role of the pharmacist , 2018, European journal of cancer care.

[6]  M. O'shaughnessy,et al.  Agreement between renal prescribing references and determination of prescribing appropriateness in hospitalized patients with chronic kidney disease , 2017, QJM : monthly journal of the Association of Physicians.

[7]  C. Trautwein,et al.  Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients , 2017, Journal of clinical pharmacy and therapeutics.

[8]  S. Namazi,et al.  A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness , 2016, Journal of research in pharmacy practice.

[9]  C. González,et al.  A Systematic Approach to Assess the Burden of Drug Interactions in Adult Kidney Transplant Patients. , 2016, Current drug safety.

[10]  Kathleen Jodoin.  The Renal Drug Handbook: The Ultimate Prescribing Guide for Renal Practitioners, 4th edition , 2016 .

[11]  Michael A. Wittie,et al.  Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support , 2015, Drug Safety.

[12]  Sarah P. Slight,et al.  On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop , 2013, BMC Medical Informatics and Decision Making.

[13]  G. Kullak-Ublick,et al.  Comparative Performance of Two Drug Interaction Screening Programmes Analysing a Cross-Sectional Prescription Dataset of 84,625 Psychiatric Inpatients , 2013, Drug Safety.

[14]  A. Bello,et al.  Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  Adriano Max Moreira Reis,et al.  Evaluation of three brands of drug interaction software for use in intensive care units , 2010, Pharmacy World & Science.

[16]  R. Lemmens‐Gruber,et al.  Clinical pharmacy services and solid organ transplantation: a literature review , 2010, Pharmacy World & Science.

[17]  S. Krähenbühl,et al.  Evaluation of frequently used drug interaction screening programs , 2008, Pharmacy World & Science.

[18]  Marvin C. Alkin,et al.  What Have We Learned? , 2019, Stumbling Blocks Against Unification.

[19]  A. Viera,et al.  Understanding interobserver agreement: the kappa statistic. , 2005, Family medicine.

[20]  Bruce Kaplan,et al.  Evaluation of Drug Interaction Software to Identify Alerts for Transplant Medications , 2005, The Annals of pharmacotherapy.

[21]  Amy J Grizzle,et al.  Concordance of severity ratings provided in four drug interaction compendia. , 2004, Journal of the American Pharmacists Association : JAPhA.

[22]  G. Devins,et al.  Differences in quality of life across renal replacement therapies: a meta-analytic comparison. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  Stanley Lemeshow,et al.  Sample Size Determination in Health Studies: A Practical Manual , 1991 .

[24]  G. Raees-Jalali,et al.  Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting. , 2020, International journal of organ transplantation medicine.

[25]  Lisa E. Hines,et al.  Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions , 2011, J. Am. Medical Informatics Assoc..

[26]  David W. Bates,et al.  Systems Analysis of Adverse Drug Events , 2008 .

[27]  R. Wolfe,et al.  Long-term survival in renal transplant recipients with graft function. , 2000, Kidney international.